Chordate Medical's Caroline Lundgren Brandberg, non-executive Director and main owner, will participate in the Fearless investor conference hosted by Feminvest in Oslo on April 25th, where she will present Chordate Medical and Ozilia Migraine. Chordate's chairman, Henrik Rammer, will also be present in Oslo. Feminvest is the largest network for female investors and entrepreneurs in the Nordic region.
"Our participation at Feminvest aligns with our increasing focus on raising awareness about the company and Ozilia across various industry and investor segments. Feminvest has a strong network of investors focused specifically on femtech and life science, where Ozilia fits into both areas," says Caroline Lundgren Brandberg, non-executive Director of Chordate Medical.
Feminvest is an acceleration network for female ownership through education, as well as an investment venture. It is currently the largest hub for female investors and entrepreneurs in the Nordic region with almost 47,000 subscribers. Feminvest also operates a network of 300 female angel investors. For Chordate Medical, the investor event in Oslo on April 25 is one of several meeting points during the spring. On the same date, the company's CEO, Anders Weilandt, will be in Switzerland showcasing Ozilia at a joint congress for specialist associations from Switzerland, Germany, and Austria.
"As Ozilia gains increasing acceptance and success in our target markets, it is natural for us to expand efforts to raise awareness for Ozilia among potential investors and buyers of the company," says Anders Weilandt, CEO of Chordate.
Caroline Lundgren Brandberg, MSc. Eng. Physics, eMBA, has been a board member of Chordate Medical since 2021. Caroline is the Global Sales Director at climate tech company Deedster and has previously worked internationally for Ericsson in various leadership roles with a focus on sales and marketing. She also holds several board and advisory board positions, including at Stockholm University.
